Harvard Bioscience Correlations
HBIO Stock | USD 0.64 0.02 3.03% |
The current 90-days correlation between Harvard Bioscience and InfuSystems Holdings is 0.37 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Harvard Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Harvard Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Harvard Bioscience Correlation With Market
Very weak diversification
The correlation between Harvard Bioscience and DJI is 0.44 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Harvard Bioscience and DJI in the same portfolio, assuming nothing else is changed.
Harvard |
Moving together with Harvard Stock
0.65 | A | Agilent Technologies | PairCorr |
0.93 | ME | 23Andme Holding | PairCorr |
0.86 | VANI | Vivani Medical Earnings Call Tomorrow | PairCorr |
0.77 | DNLI | Denali Therapeutics | PairCorr |
0.82 | VCEL | Vericel Corp Ord | PairCorr |
0.82 | VCYT | Veracyte | PairCorr |
0.9 | VERA | Vera Therapeutics | PairCorr |
0.67 | DRTS | Alpha Tau Medical | PairCorr |
0.81 | CDIOW | Cardio Diagnostics | PairCorr |
0.67 | SABSW | SAB Biotherapeutics | PairCorr |
0.86 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
0.84 | VKTX | Viking Therapeutics | PairCorr |
0.71 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
0.73 | VRAX | Virax Biolabs Group | PairCorr |
0.88 | VRDN | Viridian Therapeutics | PairCorr |
0.9 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.95 | VTYX | Ventyx Biosciences | PairCorr |
Moving against Harvard Stock
0.87 | VALN | Valneva SE ADR | PairCorr |
0.51 | EQ | Equillium | PairCorr |
0.51 | DTIL | Precision BioSciences Earnings Call This Week | PairCorr |
0.34 | DMAC | DiaMedica Therapeutics | PairCorr |
0.91 | VRNA | Verona Pharma PLC | PairCorr |
0.87 | VRTX | Vertex Pharmaceuticals | PairCorr |
0.84 | DVAX | Dynavax Technologies | PairCorr |
0.63 | VTVT | vTv Therapeutics | PairCorr |
0.61 | VSTM | Verastem | PairCorr |
0.51 | VIGL | Vigil Neuroscience | PairCorr |
0.4 | SRZNW | Surrozen Warrant | PairCorr |
0.4 | VNDA | Vanda Pharmaceuticals | PairCorr |
0.75 | EDSA | Edesa Biotech | PairCorr |
0.66 | ELTX | Elicio Therapeutics Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Harvard Stock performing well and Harvard Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Harvard Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INFU | 2.53 | (0.47) | 0.00 | (0.34) | 0.00 | 4.40 | 19.13 | |||
PDEX | 3.75 | 0.17 | 0.04 | 0.16 | 4.22 | 8.67 | 34.56 | |||
LMAT | 1.67 | (0.22) | 0.00 | (0.38) | 0.00 | 2.40 | 10.56 | |||
UTMD | 0.65 | (0.12) | 0.00 | (0.35) | 0.00 | 1.10 | 4.92 | |||
MLSS | 4.01 | 0.53 | 0.10 | 0.57 | 4.79 | 7.63 | 37.01 | |||
POCI | 2.26 | (0.05) | 0.00 | (0.17) | 0.00 | 4.44 | 13.51 | |||
KRMD | 2.81 | (0.44) | 0.00 | (0.31) | 0.00 | 6.52 | 27.21 | |||
ANGO | 2.97 | 0.32 | 0.11 | 0.36 | 2.94 | 5.00 | 46.09 | |||
ICUI | 1.71 | (0.05) | 0.00 | (0.12) | 0.00 | 3.10 | 11.84 |
Harvard Bioscience Corporate Management
Ryan Wallace | Senior Sales | Profile | |
Michael Rossi | Chief Officer | Profile | |
Kara Weiner | VP Management | Profile | |
David Sirois | Director Reporting | Profile | |
Kenneth Olson | Ex Officer | Profile | |
Kathryn Flynn | Corporate Controller | Profile |